BEAT Biotherapeutics

BEAT Biotherapeutics is a biotechnology company based in Bellevue, Washington, established in 2008. The company specializes in developing innovative therapies aimed at treating heart diseases, particularly heart failure. Its primary focus is on a groundbreaking gene therapy designed to enhance cardiac performance, which has the potential to transform the treatment landscape for heart failure and myocardial infarctions. By improving cardiac muscle contraction and facilitating faster relaxation, BEAT Biotherapeutics' therapies aim to increase the efficacy of treatment, enabling patients to commence therapy swiftly and improving their chances of successful outcomes.